Cargando…
A revised model for mitochondrial dysfunction in Duchenne muscular dystrophy
We recently identified a signaling pathway that links the upregulation of miR-379 with a mitochondrial response in dystrophic muscle. In the present commentary, we explain the significance that this pathway may have in mitochondrial dysfunction in Duchenne muscular dystrophy (DMD). We identified the...
Autores principales: | Vu Hong, Ai, Sanson, Mathilde, Richard, Isabelle, Israeli, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PAGEPress Publications, Pavia, Italy
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8495359/ https://www.ncbi.nlm.nih.gov/pubmed/34533019 http://dx.doi.org/10.4081/ejtm.2021.10012 |
Ejemplares similares
-
Cholesterol metabolism is a potential therapeutic target in Duchenne muscular dystrophy
por: Amor, Fatima, et al.
Publicado: (2021) -
miR-379 links glucocorticoid treatment with mitochondrial response in Duchenne muscular dystrophy
por: Sanson, M., et al.
Publicado: (2020) -
Dlk1-Dio3 cluster miRNAs regulate mitochondrial functions in the dystrophic muscle in Duchenne muscular dystrophy
por: Vu Hong, Ai, et al.
Publicado: (2022) -
Co-Administration of Simvastatin Does Not Potentiate the Benefit of Gene Therapy in the mdx Mouse Model for Duchenne Muscular Dystrophy
por: Bourg, Nathalie, et al.
Publicado: (2022) -
Gastrointestinal Dysfunction in Patients with Duchenne Muscular Dystrophy
por: Lo Cascio, Christian M., et al.
Publicado: (2016)